This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Porco, T. C. Articles by Blower, S. M. Search for Related Content

Designing HIV Vaccination Policies: Subtypes and Cross-Immunity

San Francisco Department of Public Health, Community Health Epidemiology Section, 25 Van Ness Avenue, Suite 710, San Francisco, California 94102
Department of Microbiology and Immunology, University of California, San Francisco, 513 Parnassus, Rm HSE 401, Box 0414, San Francisco, California 94143-0414

We developed and used mathematical models to assess vaccine programs for controlling two subtypes of HIV, both for developing countries where more than one subtype is present and for countries where only one subtype is present but other subtypes may invade. We began by formulating a model of the intrinsic transmission dynamics of the two HIV subtypes and then extended this model to include the effects of a prophylactic vaccine that provides a degree of protection against infection by one subtype and vaccine-induced cross-immunity against infection by the second subtype. Using these models, we assessed the potential impact of using a prophylactic vaccine when one subtype of HIV is endemic and a second subtype is introduced into the community. In each case, mass vaccination could result in one of four possible outcomes: (1) both subtypes are eradicated, (2) the endemic subtype persists and the invading subtype is eradicated, (3) the endemic subtype is eradicated and the invading subtype persists, or (4) both subtypes coexist.

Key Words: health care; treatment; simulations; applications